vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Loar Holdings Inc. (LOAR). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $131.8M, roughly 1.6× Loar Holdings Inc.). Loar Holdings Inc. runs the higher net margin — 9.5% vs 8.3%, a 1.2% gap on every dollar of revenue. On growth, Loar Holdings Inc. posted the faster year-over-year revenue change (19.3% vs 12.9%). Over the past eight quarters, Loar Holdings Inc.'s revenue compounded faster (19.8% CAGR vs 19.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
COLL vs LOAR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $131.8M |
| Net Profit | $17.0M | $12.5M |
| Gross Margin | 62.5% | 52.1% |
| Operating Margin | 29.6% | 18.0% |
| Net Margin | 8.3% | 9.5% |
| Revenue YoY | 12.9% | 19.3% |
| Net Profit YoY | 35.3% | 239.5% |
| EPS (diluted) | $0.48 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $131.8M | ||
| Q3 25 | $209.4M | $126.8M | ||
| Q2 25 | $188.0M | $123.1M | ||
| Q1 25 | $177.8M | $114.7M | ||
| Q4 24 | $181.9M | $110.4M | ||
| Q3 24 | $159.3M | $103.5M | ||
| Q2 24 | $145.3M | $97.0M | ||
| Q1 24 | $144.9M | $91.8M |
| Q4 25 | $17.0M | $12.5M | ||
| Q3 25 | $31.5M | $27.6M | ||
| Q2 25 | $12.0M | $16.7M | ||
| Q1 25 | $2.4M | $15.3M | ||
| Q4 24 | $12.5M | $3.7M | ||
| Q3 24 | $9.3M | $8.7M | ||
| Q2 24 | $19.6M | $7.6M | ||
| Q1 24 | $27.7M | $2.2M |
| Q4 25 | 62.5% | 52.1% | ||
| Q3 25 | 61.7% | 52.7% | ||
| Q2 25 | 57.7% | 53.8% | ||
| Q1 25 | 54.8% | 52.1% | ||
| Q4 24 | 54.0% | 48.9% | ||
| Q3 24 | 60.8% | 51.1% | ||
| Q2 24 | 62.5% | 49.0% | ||
| Q1 24 | 63.1% | 48.4% |
| Q4 25 | 29.6% | 18.0% | ||
| Q3 25 | 29.7% | 22.9% | ||
| Q2 25 | 18.7% | 22.2% | ||
| Q1 25 | 12.2% | 22.8% | ||
| Q4 24 | 20.9% | 19.2% | ||
| Q3 24 | 21.9% | 22.1% | ||
| Q2 24 | 32.7% | 22.9% | ||
| Q1 24 | 34.1% | 23.3% |
| Q4 25 | 8.3% | 9.5% | ||
| Q3 25 | 15.0% | 21.8% | ||
| Q2 25 | 6.4% | 13.6% | ||
| Q1 25 | 1.4% | 13.4% | ||
| Q4 24 | 6.9% | 3.3% | ||
| Q3 24 | 5.9% | 8.4% | ||
| Q2 24 | 13.5% | 7.9% | ||
| Q1 24 | 19.1% | 2.4% |
| Q4 25 | $0.48 | $0.13 | ||
| Q3 25 | $0.84 | $0.29 | ||
| Q2 25 | $0.34 | $0.17 | ||
| Q1 25 | $0.07 | $0.16 | ||
| Q4 24 | $0.36 | $-11023.48 | ||
| Q3 24 | $0.27 | $0.09 | ||
| Q2 24 | $0.52 | $0.09 | ||
| Q1 24 | $0.71 | $11023.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $84.8M |
| Total DebtLower is stronger | — | $715.7M |
| Stockholders' EquityBook value | $301.7M | $1.2B |
| Total Assets | $1.7B | $2.0B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $84.8M | ||
| Q3 25 | $285.9M | $99.0M | ||
| Q2 25 | $222.2M | $103.3M | ||
| Q1 25 | $197.8M | $80.5M | ||
| Q4 24 | $162.8M | $54.1M | ||
| Q3 24 | $120.0M | $55.2M | ||
| Q2 24 | $271.6M | $73.2M | ||
| Q1 24 | $318.0M | $28.2M |
| Q4 25 | — | $715.7M | ||
| Q3 25 | — | $279.4M | ||
| Q2 25 | — | $277.7M | ||
| Q1 25 | — | $277.5M | ||
| Q4 24 | — | $277.3M | ||
| Q3 24 | — | $602.1M | ||
| Q2 24 | — | $250.7M | ||
| Q1 24 | — | $534.2M |
| Q4 25 | $301.7M | $1.2B | ||
| Q3 25 | $274.8M | $1.2B | ||
| Q2 25 | $232.2M | $1.1B | ||
| Q1 25 | $234.4M | $1.1B | ||
| Q4 24 | $228.8M | $1.1B | ||
| Q3 24 | $234.3M | $769.8M | ||
| Q2 24 | $216.6M | $758.4M | ||
| Q1 24 | $222.2M | $420.6M |
| Q4 25 | $1.7B | $2.0B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.1B | $1.1B |
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | — | 1.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $30.4M |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | 2.43× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $30.4M | ||
| Q3 25 | $78.4M | $29.7M | ||
| Q2 25 | $72.4M | $23.8M | ||
| Q1 25 | $55.4M | $28.4M | ||
| Q4 24 | $84.6M | $20.7M | ||
| Q3 24 | $-9.0M | $16.3M | ||
| Q2 24 | $67.4M | $7.1M | ||
| Q1 24 | $61.9M | $10.8M |
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — | ||
| Q1 24 | $61.4M | — |
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — | ||
| Q1 24 | 42.3% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 7.25× | 2.43× | ||
| Q3 25 | 2.49× | 1.08× | ||
| Q2 25 | 6.05× | 1.42× | ||
| Q1 25 | 22.92× | 1.85× | ||
| Q4 24 | 6.75× | 5.62× | ||
| Q3 24 | -0.96× | 1.89× | ||
| Q2 24 | 3.44× | 0.93× | ||
| Q1 24 | 2.23× | 4.81× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
LOAR
| Other | $76.8M | 58% |
| Commercial Aerospace | $21.2M | 16% |
| Business Jet And General Aviation | $17.6M | 13% |
| Defense | $16.2M | 12% |
